lovastatin has been researched along with EHS Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kelleher, DK; Thews, O; Vaupel, P | 1 |
| Matar, P; Roggero, EA; Rozados, VR; Scharovsky, OG | 1 |
2 other study(ies) available for lovastatin and EHS Tumor
| Article | Year |
|---|---|
In vivo oxygen consumption rate of DS sarcoma cells on inhibition of DNA synthesis.
Topics: Animals; Antineoplastic Agents; Ascites; Cell Division; Depression, Chemical; DNA, Neoplasm; Lovastatin; Male; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Sarcoma, Experimental; Vidarabine | 1996 |
Lovastatin inhibits tumor growth and metastasis development of a rat fibrosarcoma.
Topics: Animals; Antineoplastic Agents; Cell Division; Cholesterol; Fibrosarcoma; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Neoplasm Metastasis; Rats; Rats, Inbred Strains; Sarcoma, Experimental | 1998 |